Elizabeth Yurth, M.D.

Even if you don't know it, you are probably affected by it to some degree.

So what do we do, right?

I mean, it's a little bit like a lot of the things in our world.

We're subjected to all these horrible things like microplastics.

What are you going to do about microplastics?

I don't know.

I mean, you know, you could take something as pristine as possible and they still have microplastics.

You look at things like, you know, glyphosate levels in us.

90% of my patients have high glyphosates.

I'm not going to actually be able to have them not exposed to glyphosates.

Europe is a little better than us.

So the problem is we're going to have to actually become more resilient somehow, right?

Because we're probably not going to have great ways to get rid of all of these things.

So we have to become a little bit more resilient.

So maybe this is where you have to use ongoing things like maybe cerebral lysine, like you should be doing cerebral lysine monthly, right?

Where you're actually doing something that's going to actually counteract the fact that maybe you are going to have this chronic low-level inflammation.

If we can keep it at bay, then it shouldn't develop into something horrible, right?

So now in people who have this high galactin-3 antibody or high galactin-3,

which is another marker of neuroinflammation, but more serious disease a lot of times, sometimes forming.

So we actually have a new drug that we're experimenting with called TB006 that's an antibody to galactin-3.